NuCana plc Holds Annual General Meeting
Ticker: NCNA · Form: 6-K · Filed: Jun 18, 2024 · CIK: 1709626
| Field | Detail |
|---|---|
| Company | Nucana PLC (NCNA) |
| Form Type | 6-K |
| Filed Date | Jun 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, filing, routine-report
TL;DR
NuCana plc held its AGM on June 18th. Standard 6-K filing.
AI Summary
NuCana plc held its Annual General Meeting (AGM) on June 18, 2024, at Lochside House in Edinburgh. The company, which is involved in pharmaceutical preparations, filed a Form 6-K report with the SEC.
Why It Matters
The AGM is a routine corporate event where shareholders can vote on company matters and receive updates. This filing confirms the meeting took place as scheduled.
Risk Assessment
Risk Level: low — This filing is a routine report of an annual general meeting and does not contain significant new financial or strategic information.
Key Players & Entities
- NuCana plc (company) — Registrant
- June 18, 2024 (date) — Date of AGM
- Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT (location) — Location of AGM
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.
When was NuCana plc's Annual General Meeting held?
NuCana plc held its Annual General Meeting on June 18, 2024.
Where was the Annual General Meeting held?
The Annual General Meeting was held at Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT.
What is NuCana plc's Standard Industrial Classification code?
NuCana plc's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Does NuCana plc file annual reports under Form 20-F or Form 40-F?
NuCana plc indicates that it files annual reports under Form 20-F.
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 15 · Accepted 2024-06-18 16:02:56
Filing Documents
- d853928d6k.htm (6-K) — 8KB
- 0001193125-24-163391.txt ( ) — 9KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NuCana plc By: /s/ Donald Munoz Name: Donald Munoz Title: Chief Financial Officer Date: June 18, 2024